The upgradation of the injectibles facility at Moraiya was completed and also, they expanded their manufacturing facility at Ankleshwar.Zydus Healthcare Brasil Ltd, Brazil, a wholly owned ...
Zydus will carry out early-stage development. (Image Credits: Pixabay) Zydus Lifesciences Limited on Tuesday announced its focus on the development of a combination vaccine against shigellosis and ...
New Delhi, Zydus Lifesciences Ltd on Friday reported over two-fold rise in consolidated net profit at Rs 1,086.9 crore for the first quarter ended June 30, 2023 driven by strong sales growth from ...
Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...
Zydus Lifesciences share price will remain in focus on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
New Delhi, Zydus Lifesciences on Tuesday said it has acquired UK-based LiqMeds Group for GBP 68 million (around Rs 689 crore). The Ahmedabad-based group, through its wholly-owned subsidiary Zydus ...
Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...
Zydus Lifesciences’ revenue was largely in-line with our estimates. EBITDA missed our estimates due to lower-than-expected gross profit and higher-than-expected other expenses. However, Adj. PAT ...